19 March 2012 - 21 March 2012
Queen Elizabeth II Conference Centre, London, UK
This joint initiative between The Physiological Society, the British Pharmacological Society and Wiley-Blackwell is the culmination of over two years preparation and will, over three days of extraordinary science, showcase world-leading sport and exercise-related medicine, physiology and pharmacology.
23 April 2012 - 24 April 2012
University of Leicester, UK
This two-day residential meeting brings together an exciting list of international speakers, talks chosen from the submitted abstracts and a dynamic Poster Session. Offering many opportunities to meet new people with common research interests in a friendly and social environment, the meeting follows on from previous, highly successful BPS Cell Signalling meetings held at the same venue in 2005, 2007 and 2009.
11 May 2012 - 11 May 2012
Royal College of Physicians of Ireland, Dublin, Ireland
This meeting brings together experts in the field of rational prescribing. It will appeal to all healthcare professionals involved in the prescribing of medicines in the modern era.
07 June 2012 - 09 June 2012
King's College London
CPD approval applied for
This 2.5 day course brings together neuropeptide and TRP nerve activation interests from the UK, Europe and America. There is a list of speakers who are carrying out cutting edge translational studies. In addition, there will be talks chosen from the submitted abstracts as well as poster sessions. This meeting will offer bursaries for young scientists and networking opportunities for all. We are arranging a social programme to fit with our location, right at the centre of London. This BPS meeting is combined with the 9th Joint meeting or the European Neuropeptide Club and the American Summer Neuropeptide Conference.
02 July 2012 - 05 July 2012
Edinburgh, UK
FFARmacology in diabetes – an emerging picture for the free fatty acid receptor family in disease
Organized by Simon Poucher AstraZeneca, Macclesfield, UK
Fatty acids have long been known as important metabolic substrates and as structural components of biological membranes. However, they also function as signaling molecules. Recently, a series of G protein-coupled receptors (GPRs) for FAs has been described and characterized. Fatty acid receptors have been found to be expressed on different cell types and may be highly relevant to a number of metabolic related processes and diseases. For example, expression profiling indicates a wide range of fatty acid receptors within GI tract, immune cells, adipose tissue, pancreas and CNS. This meeting is an opportunity to raise and discuss in an open forum some of the challenges associated with understanding the pharmacology of this receptor family.
04 July 2012 - 06 July 2012
Keble College, Oxford
Hosted jointly with the American Microcirculatory Society
BPS are supporting this joint meeting of the British Microcirculation Society and The Microcirculatory Society.
17 July 2012 - 20 July 2012
Granada, Spain
The 6th European Congress of Pharmacology will be an opportunity to bring together the international pharmacological community, covering the process of drug development from 'bench to bedside.'
The BPS are organizing three symposia at this meeting:
Wednesday 18 July, from 9:00-10:30
Biological and therapeutic roles of glycine receptors
Wednesday 18 July, from 16:00-17:30
Latest developments in Cys-loop receptor structure and function
Friday 20 July, from 9:00-10:30
Novel targeting of the 5-HT3 receptor for potential therapeutic benefit
07 April 2013 - 10 April 2013
The Barbican Centre
The British Neuroscience Association's biennial meeting in 2013 will be a unique event. The BPS is partnering with the BNA and other societies with a neuroscience interest - both clinical and non-clinical - to create a meeting with over thirty symposia and seven plenary speakers presenting the best neuroscience research. As the Barbican Centre is one of London's main entertainment venues, a major public engagement programme will also be organized to enable members of the public to interact with scientists, carers, charities, funders, policy makers and some well-known celebrities with experience of mental health issues.